UNSPSC 51162311: Acetaminophen/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162311 Acetaminophen/phenylephrine, a Commodity code, represents pharmaceutical products and related services that state and local governments procure for health care delivery to incarcerated populations, emergency response programs, and community health initiatives. Recent solicitations under this code show state and local buyers acquiring parenteral pharmaceutical solutions, intravenous products, controlled substances for medical use, and opioid antagonists such as naloxone. The issuing bodies include state departments of corrections and county health authorities, each with distinct supply-chain requirements driven by the nature of their patient populations and delivery constraints. The Washington State Department of Corrections, a repeat buyer in this space, requires time-sensitive pharmaceutical preparation and delivery to support medically necessary care across multiple correctional facilities, while county health agencies typically procure finished pharmaceutical products and drug-management systems for community distribution.

Recent activity centers in Washington State and Florida. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, soliciting parenteral products, services, and equipment for eight correctional facilities across three regions, with responses due October 7, 2026, and a pre-bid conference scheduled for September 23, 2026; the agency anticipates selecting up to three contractors per region and will award an initial contract term running November 26, 2026 through June 30, 2030. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building, though the solicitation notice carries an outdated response date of July 26, 2023. Both solicitations include set-aside aspirations or preferences for small, minority-owned, women-owned, and veteran-owned businesses where applicable under state law.